Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
[Meloxicam clinical effects].
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(1):36-42. doi: 10.17116/jnevro202212201136.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022.
PMID: 35175701
Russian.
A number of studies have demonstrated the efficacy and safety of meloxicam with different methods of its administration (per oral (p/o), intramuscularly (i/m)) in the treatment of pain syndrome in the lower back, with OA, etc. ...Today, the most commonly pain therapy schem …
A number of studies have demonstrated the efficacy and safety of meloxicam with different methods of its administration (per oral (p/o …
[Recognan (citicoline) efficacy and safety in cognitive impairment correction of various nosological forms].
Shavlovskaya OA, Bokova IA.
Shavlovskaya OA, et al.
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(11):22-28. doi: 10.17116/jnevro202312311122.
Zh Nevrol Psikhiatr Im S S Korsakova. 2023.
PMID: 37994884
Russian.
Therapy regimens include two-stage Recognan prescribing: with CVD intramuscularly (i/m) at 1000 mg /d for 30 days, in the acute period of ischemic stroke, i/m or intravenously (i/v) at 1000 mg every 12 hours from the first day after diagnosis, 3-5 days after the start of therapy, …
Therapy regimens include two-stage Recognan prescribing: with CVD intramuscularly (i/m) at 1000 mg /d for 30 days, in the acute period of is …
Item in Clipboard
Cite
Cite